Jean-François Patoiseau

Title: Innovator Jean-François Patoiseau: Pioneering Research in Pharmaceuticals

Introduction

Jean-François Patoiseau, a notable inventor based in Castres, France, has made significant contributions to the field of pharmaceuticals with his innovative research. With two patents to his name, he has focused on developing novel therapeutic agents with applications in treating central nervous system disorders.

Latest Patents

Patoiseau's most recent patents include groundbreaking work on chromone derivatives. This invention covers chromone derivatives, detailing their preparation, pharmaceutical compositions, and their potential use as D3 dopaminergic ligands in medicinal applications for various conditions affecting the central nervous system. His second patent involves 1,2,4-triazine derivatives, specifically 3,5-dioxo-(2H,4H)-1,2,4-triazine compounds. This invention discusses their preparation, use in human therapy, and the creation of additive salts with pharmaceutically acceptable bases, as well as various enantiomers and their mixtures.

Career Highlights

Throughout his career, Patoiseau has collaborated with prominent organizations, contributing his expertise in pharmaceutical research. His work at Pierre Fabre Medicament has been instrumental in advancing therapeutic options in the pharmaceutical industry.

Collaborations

Patoiseau has worked alongside distinguished colleagues, including Pierre Sokoloff and Thierry Imbert. These collaborations have facilitated the sharing of knowledge and innovation, ultimately contributing to the efficacy and success of his inventions.

Conclusion

Jean-François Patoiseau stands out as a dedicated inventor whose work in pharmaceutical innovation continues to impact the medical field. His groundbreaking patents reflect a commitment to enhancing treatment options for patients with central nervous system disorders, showcasing the importance of innovation in science and medicine.